Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis

被引:0
|
作者
Wu, Wenxue [1 ]
Tao, Guoqiang [1 ]
Chen, Zhiqing [2 ]
Zhou, Qi [1 ,2 ]
机构
[1] Shanghai Punan Hosp, Dept Gen Surg, 279 Linyi Rd, Shanghai, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Jiangxi Med Coll, Jiangxi Prov Key Lab Mol Med, Nanchang, Jiangxi, Peoples R China
来源
SCIENTIFIC REPORTS | 2025年 / 15卷 / 01期
关键词
Gastric cancer; Disulfidptosis; Subtypes; Single cell;
D O I
10.1038/s41598-024-83580-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent studies have found that disulfidptosis occurs in cells under glucose starvation. The role of this programmed death method in gastric cancer remains to be explored. Cluster analysis based on disulfidptosis related genes to analyze the differential characteristics of disulfidptosis subtypes. We construct a prognostic risk model using 12 differentially expressed genes of disulfidptosis subtypes. We also analyzed the disulfidptosis subtypes at single-cell resolution. We found that cluster 1 has a poor prognosis and is characterized by a younger age. Inhibiting the expression of GAMT genes associated with disulfidptosis subtypes can significantly inhibit the proliferation of gastric cancer cells, which may be an important target for gastric cancer treatment. Cluster 2 patients are more sensitive to various chemotherapy drugs and immunotherapy. Mesenchymal cells, especially myCAF, endothelial cells, and smooth muscle cells, have strong disulfidptosis scores. In summary, our study provides new insights into the role of disulfidptosis in gastric cancer, and this may be used to guide the treatment of gastric cancer.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Identification of Key Disulfidptosis-Related Genes and Their Association with Gene Expression Subtypes in Crohn's Disease
    Fu, Mingyue
    Aihemaiti, Diliaremu
    Fu, Haowen
    Li, Na
    Yuan, Yifan
    Ye, Mei
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3655 - 3670
  • [2] Identification of disulfidptosis-related clusters and construction of a disulfidptosis-related gene prognostic signature in triple-negative breast cancer
    Wu, Jie
    Cai, Yan
    Zhao, Gaiping
    HELIYON, 2024, 10 (12)
  • [3] Identification of a prognostic disulfidptosis-related gene signature in hepatocellular cancer
    Zhu, Jinhong
    Wu, Yan
    Ji, Pengyu
    Qi, Jun
    Yang, Xuekun
    Pocha, Christine
    Tustumi, Francisco
    de Castria, Tiago Biachi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04) : 1647 - 1656
  • [4] Identification of subtypes and biomarkers associated with disulfidptosis-related ferroptosis in ulcerative colitis
    Jiang, Yinghao
    Meng, Hongyan
    Zhang, Xin
    Yang, Jinguang
    Sun, Chengxin
    Wang, Xiaoyan
    HEREDITAS, 2025, 162 (01):
  • [5] Prognostic and immune infiltration features of disulfidptosis-related subtypes in breast cancer
    Chen, Sheng
    Li, Xiangrong
    Ao, Wen
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [6] Prognostic and immune infiltration features of disulfidptosis-related subtypes in breast cancer
    Sheng Chen
    Xiangrong Li
    Wen Ao
    BMC Women's Health, 24
  • [7] Hub gene of disulfidptosis-related immune checkpoints in breast cancer
    Ye Wang
    Yinmei Deng
    Hui Xie
    Sujuan Cao
    Medical Oncology, 40
  • [8] Hub gene of disulfidptosis-related immune checkpoints in breast cancer
    Wang, Ye
    Deng, Yinmei
    Xie, Hui
    Cao, Sujuan
    MEDICAL ONCOLOGY, 2023, 40 (08)
  • [9] Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma
    Jiang, Qian
    Ling, Guo-Yuan
    Yan, Jun
    Tan, Ju-Yuan
    Nong, Ren-Bao
    Li, Jian-Wen
    Deng, Teng
    Mo, Li-Gen
    Huang, Qian-Rong
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 37
  • [10] Identification of gastric cancer subtypes based on disulfidptosis-related genes: GPC3 as a novel biomarker for prognosis prediction
    Yi, Nan
    Yin, Xindong
    Feng, Xiao
    Ren, Ming
    Ma, Chaoqun
    DISCOVER ONCOLOGY, 2024, 15 (01)